An introduction to mixed effect modeling: Concepts, definitions, and justification Lewis B. SheinerThaddeus H. Grasela Jr. OriginalPaper 01 June 1991 Pages: S11 - S24
Pharmacostatistical modeling for observational data Thaddeus H. Grasela Jr.Lewis B. Sheiner OriginalPaper 01 June 1991 Pages: S25 - S36
The application of population pharmacokinetic analysis to large scale clinical efficacy trials Edward J. AntalThaddeus H. Grasela Jr.Randall B. Smith OriginalPaper 01 June 1991 Pages: S37 - S46
A population pharmacokinetic profile of imazodan in congestive heart failure patients Stephen C. Olson OriginalPaper 01 June 1991 Pages: S47 - S58
The population pharmacokinetics of theophylline during the early postnatal period Emory S. Martin III OriginalPaper 01 June 1991 Pages: S59 - S77
Population dose-response relationships determined from efficacy trials: The antihypertensive effect of atenolol and betaxolol Nancy C. SambolWilliam A. ClementiLewis B. Sheiner OriginalPaper 01 June 1991 Pages: S79 - S91
A multi-center study to evaluate the pharmacokinetic and clinical interactions between alprazolam and imipramine Edward J. AntalThaddeus H. Grasela Jr.Randall B. Smith OriginalPaper 01 June 1991 Pages: S93 - S100
Application of population analysis to physiological pharmacokinetics Thomas M. LuddenSandra R. B. AllerheiligenRaymond F. Burk OriginalPaper 01 June 1991 Pages: S101 - S113